With a focus on actionable insights and strategic value, The Business Research Company’s 2026 market reports include market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights.
Colorectal Cancer Screening Market Size Analysis: Historical Growth And Future Revenue Projections
The colorectal cancer screening market has experienced robust growth over recent years. This market is projected to expand from $16.56 billion in 2025 to $17.56 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.1%. Factors contributing to this historical expansion include an increase in the prevalence of colorectal cancer, the broadening of national screening guidelines, greater awareness regarding the advantages of early diagnosis, the adoption of fecal-based screening approaches, and enhanced availability of diagnostic services.
The colorectal cancer screening market is anticipated to undergo significant expansion in the upcoming years. It is projected to reach a value of $22.06 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 5.9%. The drivers behind this growth in the forecast period include a surge in screening adoption among younger age groups, the increasing integration of AI within endoscopy procedures, the proliferation of telehealth-supported screening initiatives, a heightened focus on personalized cancer risk assessments, and growing investments in preventive healthcare infrastructure. Prominent trends for this period encompass the rising acceptance of non-invasive screening tests, increased deployment of AI-assisted colonoscopy systems, a growing demand for home-based stool testing kits, the expansion of population-wide screening programs, and an intensified commitment to early detection and preventive care.
Preview The Colorectal Cancer Screening Market Report With A Free Sample:
Colorectal Cancer Screening Market Drivers: What Is Fueling Demand Through 2030?
The expanding aging population is anticipated to drive the growth of the colorectal cancer screening market moving forward. This demographic shift involves an increasing proportion of elderly individuals, typically 65 years and older, relative to the working-age population, often resulting from longer life expectancies and declining birth rates globally. Colorectal cancer screening plays a vital role in addressing the needs of this growing senior demographic by facilitating early detection and preventive actions, thereby managing the heightened cancer risk in older adults and improving their overall health. For example, in January 2024, figures released by the Population Reference Bureau (PRB), a US-based nonprofit research organization, project that the number of Americans aged 65 and older will increase from 58 million in 2022 to 82 million by 2050, a 47% rise, while their percentage of the total population is forecast to grow from 17% to 23%. Thus, the escalating aging population is a primary catalyst for the colorectal cancer screening market.
Colorectal Cancer Screening Market Segmentation Analysis: Core Categories And Subcategories
The colorectal cancer screening market covered in this report is segmented –
1) By Type: Stool-Based, Fecal Immunochemical Test (FIT), Fecal Occult Blood Test (FOBT), Stool Deoxyribonucleic Acid (DNA) Test, Colonoscopy, Other Types
2) By Age Group: Below 50 Years, 50-64 Years, Above 65 Years
3) By End User: Hospitals And Clinics, Clinical Laboratories, Diagnostic Imaging Centers, Other End-Users
Subsegments:
1) By Stool-Based: Stool-Based Tests
2) By Fecal Immunochemical Test (FIT): High-Sensitivity FIT, Low-Sensitivity FIT
3) By Fecal Occult Blood Test (FOBT): Guaiac FOBT, Immunochemical FOBT
4) By Stool Deoxyribonucleic Acid (DNA) Test: Multi-Target Stool DNA Test, Single-Target Stool DNA Test
5) By Colonoscopy: Diagnostic Colonoscopy, Therapeutic Colonoscopy
6) By Other Types: Virtual Colonoscopy, Flexible Sigmoidoscopy, Capsule Endoscopy
Which Trends Will Define The Colorectal Cancer Screening Market Through 2030?
Major companies operating in the colorectal cancer screening market are concentrating on developing advanced solutions such as non-invasive multi-target stool ribonucleic acid (RNA) colorectal cancer screening tests, aiming to provide an accessible and effective method for early detection of colorectal cancer, thus improving patient outcomes and encouraging broader screening participation. These non-invasive multi-target stool RNA colorectal cancer screening tests function by analyzing RNA markers from a stool sample to identify the presence of colorectal cancer or precancerous lesions, thereby offering a non-surgical approach for early detection. For instance, in May 2024, Geneoscopy Inc., a US-based life sciences company, announced the U.S. Food and Drug Administration (FDA) approval of ColoSense. This product employs RNA biomarkers for a non-invasive, stool-based screening that demonstrated 93% sensitivity for detecting colorectal cancer and 45% sensitivity for advanced adenomas. Its significance is rooted in its high accuracy, particularly within younger populations, and its potential to increase screening rates by presenting a less invasive alternative compared to traditional methods.
Colorectal Cancer Screening Market Major Companies And Industry Participants
Major companies operating in the colorectal cancer screening market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic plc, Siemens Healthineers, FUJIFILM Holdings Corporation, GE HealthCare, Boston Scientific Corporation, Olympus Corporation, Hologic Inc., bioMérieux SA, QuidelOrtho Corporation, Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Guardant Health Inc., Eiken Chemical Co. Ltd., HemoCue AB, Clinical Genomics Inc., Polymedco LLC, Hemosure Inc., Geneoscopy Inc., Novigenix SA
Buy The Full Colorectal Cancer Screening Global Market Report 2026:
Colorectal Cancer Screening Market Geographic Analysis: Which Region Accounts For The Biggest Share?
North America was the largest region in the colorectal cancer screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the colorectal cancer screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
